Shore Capital reissued their house stock rating on shares of Kore Potash (LON:KP2 - Free Report) in a research note released on Wednesday, Marketbeat.com reports.
Kore Potash Stock Performance
Shares of Kore Potash stock traded down GBX 0.26 ($0.00) during mid-day trading on Wednesday, hitting GBX 2.70 ($0.04). 5,103,230 shares of the stock were exchanged, compared to its average volume of 1,299,812. The company has a market capitalization of £147.91 million, a P/E ratio of -125,000.00 and a beta of 1.31. The company has a 50-day simple moving average of GBX 2.17 and a 200 day simple moving average of GBX 2.48. Kore Potash has a 12 month low of GBX 0.50 ($0.01) and a 12 month high of GBX 4.50 ($0.06).
Kore Potash Company Profile
(
Get Free Report)
Kore Potash Plc (AIM: KP2, ASX: KP2, JSE: KP2) is an advanced stage mineral exploration and development company that is incorporated in England and Wales and listed on AIM, a market operated by the London Stock Exchange, the Australian Securities Exchange (ASX) and the JSE Limited (JSE) in South Africa.
Through the development of the Sintoukola potash basin in the Republic of Congo (RoC), Kore Potash is working to bring a number of globally significant potash deposits into production.
See Also
Before you consider Kore Potash, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kore Potash wasn't on the list.
While Kore Potash currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.